2016
DOI: 10.1136/annrheumdis-2016-eular.2411
|View full text |Cite
|
Sign up to set email alerts
|

AB0903 Behcet's Disease in The Midwest Region of Ireland: Patient Access and Response To Anti-TNF Biologics

Abstract: BackgroundCurrent literature shows promising data for efficacy of anti-tumor necrosis factor (anti-TNF) biological therapy in Behcet's disease (BD) patients.ObjectivesThe aim was to investigate a cohort of BD patients in Midwest Region of Ireland, current prescription practice for anti TNF biologics in this cohort, patient response & the risk of serious infections or other serious side effects.MethodsAll BD patients attending our rheumatology service & satisfying the ISGBD or ICBD criteria were included in the… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles